Older Patients Are Less Affected by Radiochemotherapeutic Treatment than Younger

Table 2

Radiotherapeutic characteristics of rectal cancer patients related to age groups.

Age category (years)	Rectal cancer patients ()	Mean IR dose (Gy) (SD)	Completed IR dose () (%)	Reduced IR dose () (%)	Increased IR dose () (%)
<40	7	49.6 (1.9)	6 (85.7)	1 (14.3)	0 (0)
40–49	17	50.8 (4.3)	14 (70.6)	2 (11.8)	1 (5.9)
50–59	42	50.3 (1.9)	37 (88.1)	3 (7.1)	2 (4.8)
60–69	53	50.3 (2)	45 (84.9)	4 (7.5)	4 (7.5)
≥70	64	49.8 (2.9)	52 (78.1)	8 (12.5)	4 (6.3)
Total	183	50.2 (2.6)	150 (82)	18 (9.8)	11 (6)
<60 years	66	50.3 (2.7)	57 (83.3)	6 (9.1)	3 (4.5)
≥60 years	117	50.1 (2.5)	97 (81.2)	12 (10.3)	8 (6.8)